1. Home
  2. COHN vs CING Comparison

COHN vs CING Comparison

Compare COHN & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • CING
  • Stock Information
  • Founded
  • COHN 1999
  • CING 2012
  • Country
  • COHN United States
  • CING United States
  • Employees
  • COHN N/A
  • CING N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHN Finance
  • CING Health Care
  • Exchange
  • COHN Nasdaq
  • CING Nasdaq
  • Market Cap
  • COHN 21.6M
  • CING 21.6M
  • IPO Year
  • COHN N/A
  • CING 2021
  • Fundamental
  • Price
  • COHN $13.31
  • CING $3.65
  • Analyst Decision
  • COHN
  • CING Strong Buy
  • Analyst Count
  • COHN 0
  • CING 4
  • Target Price
  • COHN N/A
  • CING $33.00
  • AVG Volume (30 Days)
  • COHN 25.4K
  • CING 221.3K
  • Earning Date
  • COHN 11-04-2025
  • CING 11-07-2025
  • Dividend Yield
  • COHN 7.83%
  • CING N/A
  • EPS Growth
  • COHN 6.32
  • CING N/A
  • EPS
  • COHN 2.49
  • CING N/A
  • Revenue
  • COHN $185,475,000.00
  • CING N/A
  • Revenue This Year
  • COHN N/A
  • CING N/A
  • Revenue Next Year
  • COHN N/A
  • CING N/A
  • P/E Ratio
  • COHN $4.71
  • CING N/A
  • Revenue Growth
  • COHN 107.11
  • CING N/A
  • 52 Week Low
  • COHN $6.10
  • CING $3.28
  • 52 Week High
  • COHN $13.56
  • CING $6.01
  • Technical
  • Relative Strength Index (RSI)
  • COHN 70.03
  • CING 44.43
  • Support Level
  • COHN $9.40
  • CING $3.57
  • Resistance Level
  • COHN $10.51
  • CING $3.80
  • Average True Range (ATR)
  • COHN 0.76
  • CING 0.20
  • MACD
  • COHN 0.26
  • CING 0.00
  • Stochastic Oscillator
  • COHN 81.92
  • CING 23.08

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: